Qvir KIT
Product Details:
- Expiration Date 24 months from the date of manufacture
- Dosage As directed by the physician
- Salt Composition Nirmatrelvir and Ritonavir
- Pacakaging (Quantity Per Box) 17 tablets per kit
- CAS No 1809249-37-3 1379741-00-6 (for Nirmatrelvir and Ritonavir)
- Usage Oral administration for the prescribed duration
- Indication Treatment of COVID-19 in adults with mild to moderate symptoms
X
Qvir KIT Product Specifications
- 17 tablets per kit
- 1809249-37-3 1379741-00-6 (for Nirmatrelvir and Ritonavir)
- Nirmatrelvir and Ritonavir
- 24 months from the date of manufacture
- As directed by the physician
- India
- Treatment of COVID-19 in adults with mild to moderate symptoms
- Oral administration for the prescribed duration
- Pharmaceutical
- Nirmatrelvir 150 mg + Ritonavir 100 mg per dose
- Tablet
- Antiviral Combination Therapy
- Store below 30C in a dry place away from direct sunlight
- C23H32F2N4O4 (Nirmatrelvir) + C37H48N6O3S2 (Ritonavir)
- Film-coated tablets
Product Description
The four drug kit contains Tenofovir, Emtricitabine, Atazanavir and Ritonavir. These drugs can be used for both first and second line treatment of HIV.
Tell us about your requirement
Price:
Quantity
Select Unit
- 50
- 100
- 200
- 250
- 500
- 1000+
Additional detail
Mobile number
Email
Other Products in 'Antiviral Drugs' category
We deal in bulk foreign inquiries.
ACTIZA PHARMACEUTICAL PRIVATE LIMITED
GST : 24AAPCA8809B1ZQ
GST : 24AAPCA8809B1ZQ
Contact Details
- 245-405, Royal Square, Utran, Surat - 394105, Gujarat, India
- Phone : 07971189326
- Mr Milan Sojitra (BDM)
- Mobile : 07971189326
|
ACTIZA PHARMACEUTICAL
All Rights Reserved.(Terms of Use)
Developed and Managed by Infocom Network Private Limited.
Developed and Managed by Infocom Network Private Limited.
